secwatch.observer — SEC 8-K summary
======================================

Issuer:     Research Solutions, Inc. (RSSS)
CIK:        0001386301
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001104659-24-059331
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Research Solutions Q3 revenue $12.1M (+17% YoY); ARR $16.6M (+82%); adjusted EBITDA record $961K
--------------------------------------------------------------------------------

- Total revenue $12.1M, up 17% YoY; platform revenue $4.0M (+76% YoY).
- ARR grew 82% to $16.6M, with B2B ARR $11.7M and B2C ARR $4.9M.
- Net income $76K ($0.00 EPS) vs $237K ($0.01) prior; adjusted EBITDA record $961K vs $559K.
- Gross margin improved 630 bps to 45.2%; operating cash flow record over $2M.
- Launched two new product offerings: Technology Landscape and Clinical Trial Landscape.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386301/000110465924059331/0001104659-24-059331-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386301/000110465924059331/tm2413961d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-059331

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer